Ron Andrews joined Oncocyte as CEO in July 2019. Previously, he was the founder and principal of the Bethesda Group LLC, a boutique consulting
group focused on helping small and mid-stage diagnostic companies
and investment groups move emerging diagnostic content and platforms
into the marketplace. He is a passionate ambassador for the need for democratization of information into community-based environments
to better manage deadly diseases like cancer, as well as control
healthcare costs by keeping the patient and treatment close to home.